Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review

Abstract Background Febrile neutropenia (FN) is a prevalent and potentially life-threatening complication in patients with lymphoma receiving myelosuppressive chemotherapy. Pegfilgrastim is more effective than filgrastim as prophylaxis for FN. However, its usage has been limited because of its highe...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Girma Tekle Gebremariam, Atalay Mulu Fentie, Kebede Beyene, Beate Sander, Gebremedhin Beedemariam Gebretekle
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2022-12-01
Serie:	BMC Health Services Research
Soggetti:	Cost-effectiveness Febrile neutropenia Lymphoma Prophylaxis Pegfilgrastim Filgrastim
Accesso online:	https://doi.org/10.1186/s12913-022-08933-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!